TCI Wealth Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

TCI Wealth Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100	Closed	–	–	2295
2021 Q3	$0	Hold	100	–	–	﹤0.01%	2371
2021 Q2	$0	Hold	100	–	–	﹤0.01%	2311
2021 Q1	$0	Sell	100 -100	-50%	-$492	﹤0.01%	2162
2020 Q4	$1K	Hold	200	–	–	﹤0.01%	1332
2020 Q3	$1K	Hold	200	–	–	﹤0.01%	1264
2020 Q2	$1K	Hold	200	–	–	﹤0.01%	1201
2020 Q1	$1K	Hold	200	–	–	﹤0.01%	1180
2019 Q4	$1K	Hold	200	–	–	﹤0.01%	1279
2019 Q3	$1K	Buy	+200	New	+$787	﹤0.01%	1222
2016 Q4	–	Sell	-1	Closed	–	–	1353
2016 Q3	$0	Hold	1	–	–	﹤0.01%	1354
2016 Q2	$0	Buy	+1	New	+$345	﹤0.01%	1296
2016 Q1	–	Sell	-1	Closed	–	–	1322
2015 Q4	$0	Sell	1 -4	-80%	-$3.06K	﹤0.01%	1021
2015 Q3	$3K	Buy	+5	New	+$4.57K	﹤0.01%	707

Other funds holding ARMP

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SWM

SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TCI Wealth Advisors's ARMP Position: Q4 2021 in Review

TCI Wealth Advisors sold out of Armata Pharmaceuticals (ARMP) in Q4 2021, closing a stake of 100 shares.

TCI Wealth Advisors first reported a position in ARMP in Q3 2015 and held it in 13 quarters. The position peaked at $3K in Q3 2015. 17 funds tracked by Wall St. Rank hold ARMP as of Q4 2021.

TCI Wealth Advisors reported no remaining Armata Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
TCI Wealth Advisors sold 100 Armata Pharmaceuticals shares in Q4 2021.
TCI Wealth Advisors first reported a position in Armata Pharmaceuticals in Q3 2015 and held it in 13 quarters.
TCI Wealth Advisors's Armata Pharmaceuticals position peaked at $3K in Q3 2015.
17 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2021.

Based on TCI Wealth Advisors's 13F filing for Q4 2021, filed 24 Jan 2022.